STUDY SEARCH RESULTS

2 studies found for your search request:  3475A-D77

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase alfa (MK-3475A) vs In...
Condition: Metastatic Non-small Cell Lung Cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT05722015
Status: Active, not recruiting
Has Results

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase alfa (MK-3475A) vs In...
Condition: Metastatic Non-small Cell Lung Cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06212752
Status: Active, not recruiting
Has Results




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site